# Laser Ablation After Stereotactic Radiosurgery

> **NCT01651078** · — · COMPLETED · sponsor: **Monteris Medical** · enrollment: 44 (actual)

## Conditions studied

- Metastatic Brain Tumors
- Progression
- Radiation Necrosis
- Quality of Life

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01651078
- **Lead sponsor:** Monteris Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651078, "Laser Ablation After Stereotactic Radiosurgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01651078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*